Ibritumomab tiuxetan - Wikipedia
Ibritumomab tiuxetan is used to treat relapsed or refractory, low grade or transformed B cell non-Hodgkin's lymphoma (NHL), a lymphoproliferative disorder, and previously untreated follicular …
Ibritumomab Tiuxetan - NCI - National Cancer Institute
Ibritumomab tiuxetan is approved to treat: B-cell follicular non-Hodgkin lymphoma. It is used in adults: With relapsed or refractory low-grade disease. Who are having a complete or partial …
Ibritumomab tiuxetan: Uses, Interactions, Mechanism of Action ...
2005年6月13日 · Ibritumomab tiuxetan is a monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope.
Ibritumomab Tiuxetan: Indications, Side Effects, Warnings - Drugs.com
2024年3月17日 · Ibritumomab Tiuxetan. Generic name: Ibritumomab Tiuxetan [ ib-ri-TYOO-mo-mab-tye-UX-e-tan ] Brand name: Zevalin Y-90 Drug classes: CD20 monoclonal antibodies, …
Zevalin(®) (ibritumomab tiuxetan): After more than a decade …
Zevalin (®) (ibritumomab tiuxetan) is a radioactive drug product, which is the combination of a β-emitting isotope, (90)Y, linked to the anti-CD20 monoclonal antibody (mAb), rituximab.
Ibritumomab Tiuxetan - Memorial Sloan Kettering Cancer Center
2022年12月12日 · Get medical help right away if you have signs like red, swollen, blistered, or peeling skin (with or without fever); red or irritated eyes; or sores in your mouth, throat, nose, …
Ibritumomab tiuxetan | Leukemia and Lymphoma Society
Ibritumomab tiuxetan is FDA approved to treat people who have relapsed or refractory, low-grade or follicular non-Hodgkin lymphoma (NHL), including patients with follicular NHL that did not …
Ibritumomab tiuxetan radioimmunotherapy for patients with …
2002年6月15日 · Radioimmunotherapy, the administration of radionuclides conjugated to monoclonal antibodies, is an effective approach for treating patients with relapsed or refractory …
Zevalin (ibritumomab tiuxetan) dosing, indications, interactions ...
Medscape - Indication-specific dosing for Zevalin (ibritumomab tiuxetan), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation …
Ibritumomab Tiuxetan injection - Cleveland Clinic
IBRITUMOMAB TIUXETAN (EYE bri TOOM oh mab) is a monoclonal antibody that allows radiation to target specific kinds of white blood cells. It is used to treat non-Hodgkin lymphoma …